Hycells Recruitment | Continuous Exploration and Innovation
Release Date:
2023-11-21 13:46
Shanghai University 2023 Autumn On-Campus Recruitment
Shanghai University is a comprehensive university under the jurisdiction of the Shanghai Municipal Government and is a national… Universities under the “Double First-Class” Initiative It is a university under the national “211 Project” and one of the first batch of high-level local universities in Shanghai as well as a model institution for deepening reform in innovation and entrepreneurship education.
Shanghai Hycells Biotechnology, as a company Innovative Biotechnology Company , has been deeply engaged in the research and development of innovative large-molecule drugs, including cell therapy, gene therapy, and antibodies, for many years. The company adheres to Talent as the foundation, quality first, and innovation as the core. Its core values drive continuous innovation to address the pain points and challenges clients face throughout the drug development process.
On November 17, 2023, Shanghai Hycells Biotechnology, one of the many innovative pharmaceutical companies eager to recruit top talent, visited the prestigious Shanghai University and officially launched its fall campus recruitment campaign for 2023. During the event, Hycells Biotechnology engaged in in-depth and enjoyable discussions with Shanghai University students on key topics such as industry prospects, the company’s vision and growth strategy, and team building—highlighting its core values.
The photo shows the on-campus recruitment fair at Shanghai University.
We look forward to welcoming outstanding individuals like you to join us. Here, you will have the opportunity to delve into the cutting edge of industry-leading technologies and engage in meaningful exchanges and learning with top-tier pharmaceutical companies, leading scientists from major research institutes, and accomplished R&D professionals. After all, greatness is born out of the ordinary—out of each and every one of us. Let us remain passionate and driven, continuously exploring and innovating, working together to advance the drug discovery and development process, becoming an indispensable force in the industry, and empowering more pharmaceutical R&D organizations.
If you have big dreams and dare to innovate, join us today!
Supporting growth, with constant attention
Basic Benefits + Salary Structure
Base salary + performance bonus/project bonus/position-specific salary + year-end bonus
National statutory holidays
Five social insurances and one housing fund (pension, medical, work-related injury, unemployment, and maternity) plus the basic housing provident fund.
Lunch allowance, housing allowance, and transportation allowance
Other Benefits
Annual Physical Exam
Annual company outing
Department team-building and group activities during holidays
Development space
Onboarding training, job-specific skills training, and specialized project seminars
Flat management structure, emphasis on individual development, and clear career advancement pathways.
Shanghai household registration
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board